Cell Therapy Regenerative Medicine Market 2022: Industry Size, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2028
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Cell therapy is the use of stem cells or their derivatives to promote the repair of diseased, dysfunctional or damaged tissue. As technology develops, researchers can grow stem cells in the lab to differentiate into specific types of cells such as heart muscle cells, blood cells or nerve cells. This is a type of cell that helps repair damaged tissues or organs.
This report aims to provide a comprehensive presentation of the global market for Cell Therapy Regenerative Medicine study by Market Intellix gives insights concerning the market elements influencing the market, Market scope, Market division, and overlays shadow upon the leading market players featuring the positive cutthroat scene and patterns beating the years.
Global Cell Therapy Regenerative Medicine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Cell Therapy Regenerative Medicine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Cell Therapy Regenerative Medicine companies in 2021 (%)
The global Cell Therapy Regenerative Medicine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
NK Cell Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cell Therapy Regenerative Medicine include DePuy Synthes, Medtronic, ZimmerBiomet, Stryker, Acelity, MiMedx Group, Organogenesis, UniQure and Cellular Dynamics International, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
The study provides the Cell Therapy Regenerative Medicine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Segmental Outline:
Global Cell Therapy Regenerative Medicine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cell Therapy Regenerative Medicine Market Segment Percentages, by Type, 2021 (%)
NK Cell Therapy
CAR-T Cell Therapy
Others
Global Cell Therapy Regenerative Medicine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cell Therapy Regenerative Medicine Market Segment Percentages, by Application, 2021 (%)
Dermatology
Cardiovascular
Central Nervous System
Plastic Surgery
Other Medical Applications
Global Cell Therapy Regenerative Medicine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cell Therapy Regenerative Medicine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cell Therapy Regenerative Medicine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Cell Therapy Regenerative Medicine revenues share in global market, 2021 (%)
Key companies Cell Therapy Regenerative Medicine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Cell Therapy Regenerative Medicine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
DePuy Synthes
Medtronic
ZimmerBiomet
Stryker
Acelity
MiMedx Group
Organogenesis
UniQure
Cellular Dynamics International
Osiris Therapeutics
Vcanbio
Gamida Cell
Golden Meditech
Cytori
Celgene
Vericel Corporation
Guanhao Biotech
Mesoblast
Stemcell Technologies
Bellicum Pharmaceuticals
This Report Addresses:
– Market Intelligence enables effective decision-making
– Market estimates and forecasts from 2022 to 2028
– Growth opportunities and trend analysis
– Segment and regional revenue forecast for market evaluation
– Competitive strategy and analysis of market segments
– List of product innovations to stay on top.
– The impact of COVID-19 and how to survive in these fast-growing markets.
1 Introduction to Research & Analysis Reports
1.1 Cell Therapy Regenerative Medicine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cell Therapy Regenerative Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cell Therapy Regenerative Medicine Overall Market Size
2.1 Global Cell Therapy Regenerative Medicine Market Size: 2021 VS 2028
2.2 Global Cell Therapy Regenerative Medicine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Cell Therapy Regenerative Medicine Sales: 2017-2028
3 Company Landscape
3.1 Top Cell Therapy Regenerative Medicine Players in Global Market
3.2 Top Global Cell Therapy Regenerative Medicine Companies Ranked by Revenue
3.3 Global Cell Therapy Regenerative Medicine Revenue by Companies
3.4 Global Cell Therapy Regenerative Medicine Sales by Companies
3.5 Global Cell Therapy Regenerative Medicine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Cell Therapy Regenerative Medicine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Cell Therapy Regenerative Medicine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Cell Therapy Regenerative Medicine Players in Global Market
3.8.1 List of Global Tier 1 Cell Therapy Regenerative Medicine Companies
3.8.2 List of Global Tier 2 and Tier 3 Cell Therapy Regenerative Medicine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Cell Therapy Regenerative Medicine Market Size Markets, 2021 & 2028
4.1.2 NK Cell Therapy
4.1.3 CAR-T Cell Therapy
4.1.4 Others
4.2 By Type - Global Cell Therapy Regenerative Medicine Revenue & Forecasts
4.2.1 By Type - Global Cell Therapy Regenerative Medicine Revenue, 2017-2022
4.2.2 By Type - Global Cell Therapy Regenerative Medicine Revenue, 2023-2028
4.2.3 By Type - Global Cell Therapy Regenerative Medicine Revenue Market Share, 2017-2028
4.3 By Type - Global Cell Therapy Regenerative Medicine Sales & Forecasts
4.3.1 By Type - Global Cell Therapy Regenerative Medicine Sales, 2017-2022
4.3.2 By Type - Global Cell Therapy Regenerative Medicine Sales, 2023-2028
4.3.3 By Type - Global Cell Therapy Regenerative Medicine Sales Market Share, 2017-2028
4.4 By Type - Global Cell Therapy Regenerative Medicine Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Cell Therapy Regenerative Medicine Market Size, 2021 & 2028
5.1.2 Dermatology
5.1.3 Cardiovascular
5.1.4 Central Nervous System
5.1.5 Plastic Surgery
5.1.6 Other Medical Applications
5.2 By Application - Global Cell Therapy Regenerative Medicine Revenue & Forecasts
5.2.1 By Application - Global Cell Therapy Regenerative Medicine Revenue, 2017-2022
5.2.2 By Application - Global Cell Therapy Regenerative Medicine Revenue, 2023-2028
5.2.3 By Application - Global Cell Therapy Regenerative Medicine Revenue Market Share, 2017-2028
5.3 By Application - Global Cell Therapy Regenerative Medicine Sales & Forecasts
5.3.1 By Application - Global Cell Therapy Regenerative Medicine Sales, 2017-2022
5.3.2 By Application - Global Cell Therapy Regenerative Medicine Sales, 2023-2028
5.3.3 By Application - Global Cell Therapy Regenerative Medicine Sales Market Share, 2017-2028
5.4 By Application - Global Cell Therapy Regenerative Medicine Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Cell Therapy Regenerative Medicine Market Size, 2021 & 2028
6.2 By Region - Global Cell Therapy Regenerative Medicine Revenue & Forecasts
6.2.1 By Region - Global Cell Therapy Regenerative Medicine Revenue, 2017-2022
6.2.2 By Region - Global Cell Therapy Regenerative Medicine Revenue, 2023-2028
6.2.3 By Region - Global Cell Therapy Regenerative Medicine Revenue Market Share, 2017-2028
6.3 By Region - Global Cell Therapy Regenerative Medicine Sales & Forecasts
6.3.1 By Region - Global Cell Therapy Regenerative Medicine Sales, 2017-2022
6.3.2 By Region - Global Cell Therapy Regenerative Medicine Sales, 2023-2028
6.3.3 By Region - Global Cell Therapy Regenerative Medicine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Cell Therapy Regenerative Medicine Revenue, 2017-2028
6.4.2 By Country - North America Cell Therapy Regenerative Medicine Sales, 2017-2028
6.4.3 US Cell Therapy Regenerative Medicine Market Size, 2017-2028
6.4.4 Canada Cell Therapy Regenerative Medicine Market Size, 2017-2028
6.4.5 Mexico Cell Therapy Regenerative Medicine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Cell Therapy Regenerative Medicine Revenue, 2017-2028
6.5.2 By Country - Europe Cell Therapy Regenerative Medicine Sales, 2017-2028
6.5.3 Germany Cell Therapy Regenerative Medicine Market Size, 2017-2028
6.5.4 France Cell Therapy Regenerative Medicine Market Size, 2017-2028
6.5.5 U.K. Cell Therapy Regenerative Medicine Market Size, 2017-2028
6.5.6 Italy Cell Therapy Regenerative Medicine Market Size, 2017-2028
6.5.7 Russia Cell Therapy Regenerative Medicine Market Size, 2017-2028
6.5.8 Nordic Countries Cell Therapy Regenerative Medicine Market Size, 2017-2028
6.5.9 Benelux Cell Therapy Regenerative Medicine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Cell Therapy Regenerative Medicine Revenue, 2017-2028
6.6.2 By Region - Asia Cell Therapy Regenerative Medicine Sales, 2017-2028
6.6.3 China Cell Therapy Regenerative Medicine Market Size, 2017-2028
6.6.4 Japan Cell Therapy Regenerative Medicine Market Size, 2017-2028
6.6.5 South Korea Cell Therapy Regenerative Medicine Market Size, 2017-2028
6.6.6 Southeast Asia Cell Therapy Regenerative Medicine Market Size, 2017-2028
6.6.7 India Cell Therapy Regenerative Medicine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Cell Therapy Regenerative Medicine Revenue, 2017-2028
6.7.2 By Country - South America Cell Therapy Regenerative Medicine Sales, 2017-2028
6.7.3 Brazil Cell Therapy Regenerative Medicine Market Size, 2017-2028
6.7.4 Argentina Cell Therapy Regenerative Medicine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Cell Therapy Regenerative Medicine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Cell Therapy Regenerative Medicine Sales, 2017-2028
6.8.3 Turkey Cell Therapy Regenerative Medicine Market Size, 2017-2028
6.8.4 Israel Cell Therapy Regenerative Medicine Market Size, 2017-2028
6.8.5 Saudi Arabia Cell Therapy Regenerative Medicine Market Size, 2017-2028
6.8.6 UAE Cell Therapy Regenerative Medicine Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 DePuy Synthes
7.1.1 DePuy Synthes Corporate Summary
7.1.2 DePuy Synthes Business Overview
7.1.3 DePuy Synthes Cell Therapy Regenerative Medicine Major Product Offerings
7.1.4 DePuy Synthes Cell Therapy Regenerative Medicine Sales and Revenue in Global (2017-2022)
7.1.5 DePuy Synthes Key News
7.2 Medtronic
7.2.1 Medtronic Corporate Summary
7.2.2 Medtronic Business Overview
7.2.3 Medtronic Cell Therapy Regenerative Medicine Major Product Offerings
7.2.4 Medtronic Cell Therapy Regenerative Medicine Sales and Revenue in Global (2017-2022)
7.2.5 Medtronic Key News
7.3 ZimmerBiomet
7.3.1 ZimmerBiomet Corporate Summary
7.3.2 ZimmerBiomet Business Overview
7.3.3 ZimmerBiomet Cell Therapy Regenerative Medicine Major Product Offerings
7.3.4 ZimmerBiomet Cell Therapy Regenerative Medicine Sales and Revenue in Global (2017-2022)
7.3.5 ZimmerBiomet Key News
7.4 Stryker
7.4.1 Stryker Corporate Summary
7.4.2 Stryker Business Overview
7.4.3 Stryker Cell Therapy Regenerative Medicine Major Product Offerings
7.4.4 Stryker Cell Therapy Regenerative Medicine Sales and Revenue in Global (2017-2022)
7.4.5 Stryker Key News
7.5 Acelity
7.5.1 Acelity Corporate Summary
7.5.2 Acelity Business Overview
7.5.3 Acelity Cell Therapy Regenerative Medicine Major Product Offerings
7.5.4 Acelity Cell Therapy Regenerative Medicine Sales and Revenue in Global (2017-2022)
7.5.5 Acelity Key News
7.6 MiMedx Group
7.6.1 MiMedx Group Corporate Summary
7.6.2 MiMedx Group Business Overview
7.6.3 MiMedx Group Cell Therapy Regenerative Medicine Major Product Offerings
7.6.4 MiMedx Group Cell Therapy Regenerative Medicine Sales and Revenue in Global (2017-2022)
7.6.5 MiMedx Group Key News
7.7 Organogenesis
7.7.1 Organogenesis Corporate Summary
7.7.2 Organogenesis Business Overview
7.7.3 Organogenesis Cell Therapy Regenerative Medicine Major Product Offerings
7.7.4 Organogenesis Cell Therapy Regenerative Medicine Sales and Revenue in Global (2017-2022)
7.7.5 Organogenesis Key News
7.8 UniQure
7.8.1 UniQure Corporate Summary
7.8.2 UniQure Business Overview
7.8.3 UniQure Cell Therapy Regenerative Medicine Major Product Offerings
7.8.4 UniQure Cell Therapy Regenerative Medicine Sales and Revenue in Global (2017-2022)
7.8.5 UniQure Key News
7.9 Cellular Dynamics International
7.9.1 Cellular Dynamics International Corporate Summary
7.9.2 Cellular Dynamics International Business Overview
7.9.3 Cellular Dynamics International Cell Therapy Regenerative Medicine Major Product Offerings
7.9.4 Cellular Dynamics International Cell Therapy Regenerative Medicine Sales and Revenue in Global (2017-2022)
7.9.5 Cellular Dynamics International Key News
7.10 Osiris Therapeutics
7.10.1 Osiris Therapeutics Corporate Summary
7.10.2 Osiris Therapeutics Business Overview
7.10.3 Osiris Therapeutics Cell Therapy Regenerative Medicine Major Product Offerings
7.10.4 Osiris Therapeutics Cell Therapy Regenerative Medicine Sales and Revenue in Global (2017-2022)
7.10.5 Osiris Therapeutics Key News
7.11 Vcanbio
7.11.1 Vcanbio Corporate Summary
7.11.2 Vcanbio Cell Therapy Regenerative Medicine Business Overview
7.11.3 Vcanbio Cell Therapy Regenerative Medicine Major Product Offerings
7.11.4 Vcanbio Cell Therapy Regenerative Medicine Sales and Revenue in Global (2017-2022)
7.11.5 Vcanbio Key News
7.12 Gamida Cell
7.12.1 Gamida Cell Corporate Summary
7.12.2 Gamida Cell Cell Therapy Regenerative Medicine Business Overview
7.12.3 Gamida Cell Cell Therapy Regenerative Medicine Major Product Offerings
7.12.4 Gamida Cell Cell Therapy Regenerative Medicine Sales and Revenue in Global (2017-2022)
7.12.5 Gamida Cell Key News
7.13 Golden Meditech
7.13.1 Golden Meditech Corporate Summary
7.13.2 Golden Meditech Cell Therapy Regenerative Medicine Business Overview
7.13.3 Golden Meditech Cell Therapy Regenerative Medicine Major Product Offerings
7.13.4 Golden Meditech Cell Therapy Regenerative Medicine Sales and Revenue in Global (2017-2022)
7.13.5 Golden Meditech Key News
7.14 Cytori
7.14.1 Cytori Corporate Summary
7.14.2 Cytori Business Overview
7.14.3 Cytori Cell Therapy Regenerative Medicine Major Product Offerings
7.14.4 Cytori Cell Therapy Regenerative Medicine Sales and Revenue in Global (2017-2022)
7.14.5 Cytori Key News
7.15 Celgene
7.15.1 Celgene Corporate Summary
7.15.2 Celgene Business Overview
7.15.3 Celgene Cell Therapy Regenerative Medicine Major Product Offerings
7.15.4 Celgene Cell Therapy Regenerative Medicine Sales and Revenue in Global (2017-2022)
7.15.5 Celgene Key News
7.16 Vericel Corporation
7.16.1 Vericel Corporation Corporate Summary
7.16.2 Vericel Corporation Business Overview
7.16.3 Vericel Corporation Cell Therapy Regenerative Medicine Major Product Offerings
7.16.4 Vericel Corporation Cell Therapy Regenerative Medicine Sales and Revenue in Global (2017-2022)
7.16.5 Vericel Corporation Key News
7.17 Guanhao Biotech
7.17.1 Guanhao Biotech Corporate Summary
7.17.2 Guanhao Biotech Business Overview
7.17.3 Guanhao Biotech Cell Therapy Regenerative Medicine Major Product Offerings
7.17.4 Guanhao Biotech Cell Therapy Regenerative Medicine Sales and Revenue in Global (2017-2022)
7.17.5 Guanhao Biotech Key News
7.18 Mesoblast
7.18.1 Mesoblast Corporate Summary
7.18.2 Mesoblast Business Overview
7.18.3 Mesoblast Cell Therapy Regenerative Medicine Major Product Offerings
7.18.4 Mesoblast Cell Therapy Regenerative Medicine Sales and Revenue in Global (2017-2022)
7.18.5 Mesoblast Key News
7.19 Stemcell Technologies
7.19.1 Stemcell Technologies Corporate Summary
7.19.2 Stemcell Technologies Business Overview
7.19.3 Stemcell Technologies Cell Therapy Regenerative Medicine Major Product Offerings
7.19.4 Stemcell Technologies Cell Therapy Regenerative Medicine Sales and Revenue in Global (2017-2022)
7.19.5 Stemcell Technologies Key News
7.20 Bellicum Pharmaceuticals
7.20.1 Bellicum Pharmaceuticals Corporate Summary
7.20.2 Bellicum Pharmaceuticals Business Overview
7.20.3 Bellicum Pharmaceuticals Cell Therapy Regenerative Medicine Major Product Offerings
7.20.4 Bellicum Pharmaceuticals Cell Therapy Regenerative Medicine Sales and Revenue in Global (2017-2022)
7.20.5 Bellicum Pharmaceuticals Key News
8 Global Cell Therapy Regenerative Medicine Production Capacity, Analysis
8.1 Global Cell Therapy Regenerative Medicine Production Capacity, 2017-2028
8.2 Cell Therapy Regenerative Medicine Production Capacity of Key Manufacturers in Global Market
8.3 Global Cell Therapy Regenerative Medicine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Cell Therapy Regenerative Medicine Supply Chain Analysis
10.1 Cell Therapy Regenerative Medicine Industry Value Chain
10.2 Cell Therapy Regenerative Medicine Upstream Market
10.3 Cell Therapy Regenerative Medicine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Cell Therapy Regenerative Medicine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Research Methodology:
Cell Therapy Regenerative Medicine Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|